Bolbrinker, Juliane <br/><br/>
Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Jan 2006 
 - 8-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-3565 
<br/><br/><label>Standard No.: </label>10.1124/jpet.105.093112  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Animals<br/>Animals, Genetically Modified<br/>Blood Pressure--drug effects<br/>Blotting, Western<br/>Body Weight--drug effects<br/>Gelatin--metabolism<br/>Gene Expression Regulation, Enzymologic--drug effects<br/>Glomerular Mesangium--physiopathology<br/>Hypertension--physiopathology<br/>Immunohistochemistry<br/>Kidney Diseases--physiopathology<br/>Male<br/>Matrix Metalloproteinase 2--biosynthesis<br/>Matrix Metalloproteinase 9--biosynthesis<br/>Matrix Metalloproteinase Inhibitors<br/>RNA, Messenger--biosynthesis<br/>Rats<br/>Rats, Sprague-Dawley<br/>Renin-Angiotensin System--physiology<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Serine Endopeptidases--genetics<br/>Tissue Inhibitor of Metalloproteinase-1--physiology<br/>Tissue Inhibitor of Metalloproteinase-2--physiology<br/>Transforming Growth Factor beta--biosynthesis<br/>Transforming Growth Factor beta1